ALSO NOTED: Roche gets OK to reintroduce Viracept in Europe; Japanese brewer may buy local drug maker;

> Roche can sell Viracept in the European Union again; regulators there reinstated the drug maker's license for the HIV remedy. Report

> Japanese brewer Kirin, faced with declining beer sales, wants to beef up its pharma business, possibly by acquiring midsize drug maker Kyowa Hakko. Report

> Indian drug maker Ranbaxy Laboratories posted skyrocketing profits for the third quarter--$50 million on sales of $406 million, some 48 percent higher than the same period last year. Much of the gain was due to the strong rupee, however; factoring out that effect, profits rose 13 percent. Report

> Sanofi Pasteur won FDA approval for its meningococcal vaccine, Menactra, for use in kids ages 2 through 10; it was already approved for those 11 through 55. Report

> In all the hoopla over the new FDA funding-and-reform legislation last month, a key provision was eclipsed--the creation of a new research center paid for by drug makers. Report

And Finally... A sweet idea: Scientists are advising surgeons to consider using honey to speed wound healing and reduce infection. Report